Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

ABSTRACT: The primary purpose of this study is to see if Sym024 is safe and tolerable as monotherapy and in combination with Sym021 in patients with solid tumor malignancies.

DISEASE(S): Neoplasm Metastasis,Solid Tumor,Metastatic Cancer,Neoplasms

PROVIDER: 2361054 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR